Employees: 02 (2023.0)Legal category: Société à responsabilité limitée (sans autre indication)Size: PMECreation date: 2009-03-24 (17 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: GRIEGES (01290), Ain
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE JEAN MICHEL GRIZARD : revenue, balance sheet and financial ratios
PHARMACIE JEAN MICHEL GRIZARD is a French company
founded 17 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in GRIEGES (01290),
this company of category PME
shows in 2025 a net income positive of 48 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE JEAN MICHEL GRIZARD (SIREN 511360083)
Indicator
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net income
47 673 €
-93 285 €
-109 601 €
1 054 €
7 808 €
72 319 €
138 649 €
164 623 €
194 413 €
186 873 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
Im Jahr 2025 erzielt PHARMACIE JEAN MICHEL GRIZARD ein positives Nettoergebnis von 48 k€. Entwicklung 2016-2025: 187 k€ -> 48 k€.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
47 673 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
Die Verschuldungsquote (= Finanzschulden / Eigenkapital x 100) beträgt 2%. Dieses niedrige Niveau spiegelt eine solide Finanzstruktur wider. Die finanzielle Autonomie (= Eigenkapital / Bilanzsumme x 100) erreicht 83%. Diese hohe Autonomie bedeutet, dass das Unternehmen den Großteil seiner Vermögenswerte durch Eigenkapital finanziert.
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
2.219%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
83.419%
Asset age ratio (2025)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution PHARMACIE JEAN MICHEL GRIZARD
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Debt ratio
59.381
38.856
24.537
13.39
4.931
0.423
0.271
0.294
5.218
2.219
Financial autonomy
59.126
67.725
75.86
83.086
87.682
89.39
88.796
89.062
81.663
83.419
Repayment capacity
None
None
None
None
None
None
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
None%
None%
None%
None%
None%
Sector positioning
Verschuldungsgrad
2.222025
2023
2024
2025
Q1: 13.71
Med: 49.76
Q3: 129.07
Ausgezeichnet
Im Jahr 2025 liegt in den unteren 25% der Branche, was positiv ist das verschuldungsgrad von PHARMACIE JEAN MICHEL GRI... (2.22). Dieses Verhältnis misst das Gewicht der Schulden im Verhältnis zum Eigenkapital. Ein niedriges Verhältnis zeigt eine solide Finanzstruktur mit geringer Abhängigkeit von Gläubigern.
Finanzielle Autonomie
83.42%2025
2023
2024
2025
Q1: 33.42%
Med: 53.71%
Q3: 72.08%
Ausgezeichnet+9 pts over 3 years
Im Jahr 2025 liegt in den oberen 25% der Branche das finanzielle autonomie von PHARMACIE JEAN MICHEL GRI... (83.4%). Dieses Verhältnis stellt den Anteil des Eigenkapitals an der Gesamtfinanzierung dar. Hohe Autonomie spiegelt finanzielle Unabhängigkeit und Fähigkeit wider, Schocks zu absorbieren.
Liquidity ratios
Die Liquiditätsquote beträgt 146.18. Das Unternehmen verfügt über 2€ liquide Mittel für jeden 1€ kurzfristiger Schulden.
Liquidity ratio (2025)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
146.176
Liquidity indicators evolution PHARMACIE JEAN MICHEL GRIZARD
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Liquidity ratio
491.269
491.712
529.567
484.789
333.339
238.032
217.408
164.393
141.049
146.176
Interest coverage
None
None
None
None
None
None
None
None
None
None
Sector positioning
Liquiditätsquote
146.182025
2023
2024
2025
Q1: 131.03
Med: 182.29
Q3: 258.7
Average-6 pts over 3 years
Im Jahr 2025 liegt unter dem Median der Branche das liquiditätsquote von PHARMACIE JEAN MICHEL GRI... (146.18). Dieses Verhältnis misst die Fähigkeit, kurzfristige Schulden mit Umlaufvermögen zu decken. Eine Verbesserung würde die Wettbewerbsposition stärken.
Working capital requirement (WCR) and payment terms
Der Betriebskapitalbedarf (WCR) misst die zeitliche Lücke.
Operating WCR (2025)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2025)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2025)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2025)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PHARMACIE JEAN MICHEL GRIZARD
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Operating WCR
0 €
0 €
0 €
0 €
0 €
0 €
0 €
0 €
0 €
0 €
Inventory turnover (days)
0
0
0
0
0
0
0
0
0
0
Customer payment term (days)
97
122
145
114
0
0
0
0
0
0
Supplier payment term (days)
283
332
458
460
0
0
0
0
0
0
Positioning of PHARMACIE JEAN MICHEL GRIZARD in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 277 transactions of similar company sales
in 2025,
the value of PHARMACIE JEAN MICHEL GRIZARD is estimated at
757 291 €
(range 513 901€ - 1 188 294€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2025
277 transactions
513k€757k€1188k€
757 291 €Range: 513 901€ - 1 188 294€
NAF 5 année 2025
Valuation method used
Net Income Multiple
47 673 €
×
15.9x
=757 291 €
Range: 513 901€ - 1 188 294€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE JEAN MICHEL GRIZARD with other companies in the same sector:
Frequently asked questions about PHARMACIE JEAN MICHEL GRIZARD
What is the revenue of PHARMACIE JEAN MICHEL GRIZARD ?
The revenue of PHARMACIE JEAN MICHEL GRIZARD is not publicly disclosed (confidential accounts filed with INPI).
Is PHARMACIE JEAN MICHEL GRIZARD profitable?
Yes, PHARMACIE JEAN MICHEL GRIZARD generated a net profit of 48 k€ in 2025.
Where is the headquarters of PHARMACIE JEAN MICHEL GRIZARD ?
The headquarters of PHARMACIE JEAN MICHEL GRIZARD is located in GRIEGES (01290), in the department Ain.
Where to find the tax return of PHARMACIE JEAN MICHEL GRIZARD ?
The tax return of PHARMACIE JEAN MICHEL GRIZARD is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE JEAN MICHEL GRIZARD operate?
PHARMACIE JEAN MICHEL GRIZARD operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart